A detailed history of J. Stern & Co. LLP transactions in Abbott Laboratories stock. As of the latest transaction made, J. Stern & Co. LLP holds 299,133 shares of ABT stock, worth $34.7 Million. This represents 3.63% of its overall portfolio holdings.

Number of Shares
299,133
Previous 295,156 1.35%
Holding current value
$34.7 Million
Previous $30.7 Billion 11.2%
% of portfolio
3.63%
Previous 3.65%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $397,978 - $469,803
3,977 Added 1.35%
299,133 $34.1 Billion
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $29.7 Million - $33.2 Million
295,156 New
295,156 $30.7 Billion
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $19.1 Million - $23.4 Million
211,927 New
211,927 $24 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track J. Stern & Co. LLP Portfolio

Follow J. Stern & Co. LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Stern & Co. LLP, based on Form 13F filings with the SEC.

News

Stay updated on J. Stern & Co. LLP with notifications on news.